Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
For the first time in nearly four years, the yield on 20-year US Treasury bonds closes below that of 30-year Treasuries

For the first time in nearly four years, the yield on 20-year US Treasury bonds closes below that of 30-year Treasuries

金色财经金色财经2025/07/08 15:43
Show original

According to Jinse Finance, the yield on the US 20-year Treasury closed below that of the 30-year Treasury on Monday, marking the first time in nearly four years and reflecting a partial normalization of the long end of the US Treasury yield curve. The continued rise in long-term Treasury yields is driven by market expectations that the Federal Reserve will begin cutting interest rates, coupled with bets that an expanding fiscal deficit will lead to increased Treasury supply. On Monday, the yield on the longest-maturity US Treasury—the 30-year bond—was slightly higher than that of the 20-year bond in late trading, the first occurrence since October 2021. On Tuesday, the 30-year Treasury yield remained less than one basis point higher than the 20-year yield. In 2022, the Federal Reserve’s rate hike cycle pushed yields on all maturities of US Treasuries higher, with the 20-year yield at one point exceeding the 30-year yield by as much as 30 basis points.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US EV landscape after subsidy cuts: traditional automakers cut and halt production, Tesla (TSLA.US) regains the majority share with Model Y

As traditional automakers cut back on their loss-making electric vehicle businesses, Tesla (TSLA.US) has regained more than half of the US electric vehicle market share.

智通财经2026/09/14 01:06
The US EV landscape after subsidy cuts: traditional automakers cut and halt production, Tesla (TSLA.US) regains the majority share with Model Y

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经2026/09/14 00:46
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas